择期无症状腹主动脉瘤日间EVAR患者筛选研究
该回顾性研究分析了5年内272例择期EVAR患者,评估哪些患者适合术后6小时内出院或在独立日间手术中心接受EVAR。结果显示55%的患者符合当日出院条件,但预测模型敏感性仅63%,不足以支持在独立日间手术中心开展EVAR。
要点
- 55%的择期EVAR患者符合术后6小时内出院标准。
- PEVAR失败、超适应症使用PEVAR和Endologix AFX移植物是术后6小时后不良事件的独立预测因素。
- 预测模型敏感性不足,不支持在独立日间手术中心开展EVAR,但医院内日间入院当日出院可行。
核心结论
- 超过一半的EVAR患者术后6小时内可准备出院。
- PEVAR失败、主动脉袖套和Endologix AFX移植物是术后6小时及以上发生或需治疗MAE或AE的独立预测因素。
- 预测模型的敏感性不足以支持在独立日间手术中心开展EVAR,但医院内日间入院当日出院可行。
研究设计与样本
- 回顾性病历审查,纳入5年内在大学医学中心进行的272例择期EVAR。
- 平均年龄74岁(范围52-94岁),75%为男性。
主要发现
- 21例患者(7.7%)发生25次术中主要不良事件(MAE):出血(5.9%)、血栓形成(1.8%)、动脉损伤(1.8%)。
- 260例(96%)尝试经皮EVAR(PEVAR),238例(88%)成功;PEVAR失败与术中MAE相关(P < .001)。
- 43例(15.8%)发生术中/术后MAE联合事件;17例(6%)需入住ICU,其中88%直接来自手术室/麻醉后监护室。
- 仅2例MAE(0.7%)发生在6小时之后(24小时充血性心力衰竭,15小时血栓形成/再手术)。
- 其他AE包括恶心(17%)、血压改变(15%)和尿潴留(13%);131例(48%)需要非常规服务或其他AE治疗,其中79例(29%)在术后≥6小时发生或需要治疗。
临床怎么用
- 超过一半的择期EVAR患者可考虑医院内日间入院并在术后6小时内当日出院。
- 不推荐在独立日间手术中心开展EVAR,因预测模型敏感性不足。
- 对于PEVAR失败、使用主动脉袖套或Endologix AFX移植物的患者,应预期术后可能需延长观察或住院。
局限性
- 回顾性单中心研究,结果外推需谨慎。
- 预测模型敏感性仅63%,不足以支持在独立日间手术中心开展EVAR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify candidates undergoing elective endovascular aneurysm repair (EVAR) of asymptomatic infrarenal abdominal aortic aneurysm who are eligible for early (≤6 hours) hospital discharge or to have EVAR performed in free-standing ambulatory surgery centers. METHODS: A retrospective medical record review of all elective EVAR performed at a university medical center over 5 years was undertaken. Potential candidates for early discharge or to have EVAR performed in a free-standing ambulatory surgery setting were defined as those who used routine monitoring services only or had self-limited minor adverse events (AE) that were identified, treated, and resolved within 6 hours of surgery. Risk factors for ineligibility were determined by logistic regression. Sensitivity, specificity, negative and positive predictive values were measured to determine the veracity of the risk factor profile. RESULTS: There were 272 elective EVARs; the mean patient age was 74 years (range, 52-94 years), and 75% were male. Twenty-five operative major AEs (MAE) occurred in 21 patients (7.7%): bleeding (5.9%), thrombosis (1.8%), and arterial injury (1.8%). Percutaneous EVAR (PEVAR) attempted in 260 patients (96%) was successful in 238 (88%). Failed PEVAR was associated with operative MAE (P < .001). Combined operative/postoperative MAE occurred in 43 patients (15.8%); 17 (6%) required intensive care admission; 88% directly from the operating room/postanesthesia care unit. Only two MAE (0.7%) occurred beyond 6 hours; (congestive heart failure at 24 hours, thrombosis/reoperation at 15 hours). Other AE included nausea (17%), blood pressure alteration (15%), and urinary retention (13%). Need for nonroutine services or treatment of other AE occurred in 131 (48%) patients with 79 (29%) developing or requiring treatment ≥6 hours postoperatively. However, 22 (8%) were treated/resolved in <6 hours; 30 (11%) patients required monitoring only and 36% had no complications, so, overall eligibility for same-day discharge/free-standing ambulatory surgery center was 55%. Failed PEVAR (odds ratio [OR], 2.37; 95% confidence interval [CI], 1.25-4.49; P = .008), PEVAR performed outside of instructions for use (IFU) criteria (OR, 2.84; 95% CI, 1.07-7.56; P = .037), Endologix AFX graft (OR, 1.66; 95% CI, 1.19-2.33; P = .003) were independent predictors of MAE or AE occurring/requiring treatment >6 hours postoperatively; EVAR, which did not require an additional aortic cuff, was associated with a lower incidence (OR, 0.17; 95% CI, 0.04-0.65; P = .01). Neither aortic nor limb IFU were independent predictors. Profiles using PEVAR IFU, PEVAR failure, and graft type demonstrated only moderate sensitivity (63%), specificity (71%), positive predictive value (70%), and negative predictive value (63%). CONCLUSIONS: More than one-half of all patients who undergo EVAR are ready for discharge within 6 hours postoperatively. Failed PEVAR, aortic cuffs, and Endologix AFX graft were independent predictors of MAE or AE occurring/requiring treatment for ≥6 hours. However, sensitivity parameters of this profile were insufficient to advocate EVAR in free-standing ambulatory surgical units at this time, but hospital-based ambulatory admission with same-day discharge would be a viable option because of easy inpatient transition for those requiring continued care.
引用
- Montross BC, O'Brien-Irr MS, Koudoumas D, et al. The selection of patients for ambulatory endovascular aneurysm repair of elective asymptomatic abdominal aortic aneurysm. J Vasc Surg. 2020. PMID: 32471738. doi:10.1016/j.jvs.2020.01.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。